Do analysts prefer ACB or CGC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Canopy Growth 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Does the media refer more to ACB or CGC?

In the previous week, Canopy Growth had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 9 mentions for Canopy Growth and 8 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 1.42 beat Aurora Cannabis' score of 0.29 indicating that Canopy Growth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Canopy Growth 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer CRON or CGC?

Cronos Group presently has a consensus price target of $2.30, suggesting a potential downside of 31.55%. Given Cronos Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cronos Group is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Canopy Growth 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Does the media prefer CRON or CGC?

In the previous week, Cronos Group had 3 more articles in the media than Canopy Growth. MarketBeat recorded 12 mentions for Cronos Group and 9 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 1.42 beat Cronos Group's score of 0.96 indicating that Canopy Growth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Canopy Growth 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend CGC or OGI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts rate SNDL or CGC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SNDL 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Canopy Growth 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Which has stronger valuation and earnings, SNDL or CGC?

SNDL has higher revenue and earnings than Canopy Growth. SNDL is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SNDL $677.32M 0.49 -$11.29M -$0.06 N/A Canopy Growth $251.01M 1.21 -$190.29M -$0.45 N/A

Is SNDL or CGC more profitable?

SNDL has a net margin of -6.39% compared to Canopy Growth's net margin of -65.33%. SNDL's return on equity of -1.68% beat Canopy Growth's return on equity. Company Net Margins Return on Equity Return on Assets SNDL -6.39% -1.68% -1.39% Canopy Growth -65.33% -21.91% -14.34%

Does the media prefer SNDL or CGC?

In the previous week, SNDL had 12 more articles in the media than Canopy Growth. MarketBeat recorded 21 mentions for SNDL and 9 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 1.42 beat SNDL's score of 0.44 indicating that Canopy Growth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SNDL 7 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Canopy Growth 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer CGC or TLRY?

Tilray Brands has a consensus target price of $5.90, indicating a potential upside of 123.48%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Tilray Brands 2 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.38

Does the media favor CGC or TLRY?

In the previous week, Tilray Brands had 4 more articles in the media than Canopy Growth. MarketBeat recorded 13 mentions for Tilray Brands and 9 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 1.42 beat Tilray Brands' score of 0.87 indicating that Canopy Growth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tilray Brands 5 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Canopy Growth (CGC) Competitors

$0.66 -0.02 (-2.52%)

As of 10:31 AM Eastern

Compare

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

Should you buy Canopy Growth stock or one of its competitors? Canopy Growth's main competitors and comparable companies include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). Companies are selected based on similarities in market, industry, and size.

How does Canopy Growth compare to Aurora Cannabis?

Aurora Cannabis (NASDAQ:ACB) and Canopy Growth (NASDAQ:CGC) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 3.3% of Canopy Growth shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 0.4% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Aurora Cannabis has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

Aurora Cannabis has a net margin of -32.26% compared to Canopy Growth's net margin of -65.33%. Aurora Cannabis' return on equity of 4.37% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-32.26%	4.37%	3.45%
Canopy Growth	-65.33%	-21.91%	-14.34%

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$314.07M	0.85	-$88.13M	-$1.41	N/A
Canopy Growth	$251.01M	1.21	-$190.29M	-$0.45	N/A

In the previous week, Canopy Growth had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 9 mentions for Canopy Growth and 8 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 1.42 beat Aurora Cannabis' score of 0.29 indicating that Canopy Growth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Canopy Growth	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Canopy Growth beats Aurora Cannabis on 9 of the 15 factors compared between the two stocks.

How does Canopy Growth compare to Cronos Group?

Cronos Group (NASDAQ:CRON) and Canopy Growth (NASDAQ:CGC) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

Cronos Group has higher earnings, but lower revenue than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	8.45	-$9.45M	$0.20	16.80
Canopy Growth	$251.01M	1.21	-$190.29M	-$0.45	N/A

Cronos Group has a net margin of 39.08% compared to Canopy Growth's net margin of -65.33%. Cronos Group's return on equity of 4.85% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.08%	4.85%	4.62%
Canopy Growth	-65.33%	-21.91%	-14.34%

In the previous week, Cronos Group had 3 more articles in the media than Canopy Growth. MarketBeat recorded 12 mentions for Cronos Group and 9 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 1.42 beat Cronos Group's score of 0.96 indicating that Canopy Growth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Canopy Growth	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cronos Group presently has a consensus price target of $2.30, suggesting a potential downside of 31.55%. Given Cronos Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cronos Group is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by company insiders. Comparatively, 0.4% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cronos Group has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

Summary

Cronos Group beats Canopy Growth on 15 of the 17 factors compared between the two stocks.

How does Canopy Growth compare to Organigram Global?

Canopy Growth (NASDAQ:CGC) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

Organigram Global has a net margin of 28.14% compared to Canopy Growth's net margin of -65.33%. Organigram Global's return on equity of -13.39% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-65.33%	-21.91%	-14.34%
Organigram Global	28.14%	-13.39%	-8.67%

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.4% of Canopy Growth shares are held by insiders. Comparatively, 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Canopy Growth has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.5, suggesting that its stock price is 50% more volatile than the broader market.

Organigram Global has lower revenue, but higher earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.21	-$190.29M	-$0.45	N/A
Organigram Global	$185.07M	0.73	-$17.70M	$0.46	2.09

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Canopy Growth had 8 more articles in the media than Organigram Global. MarketBeat recorded 9 mentions for Canopy Growth and 1 mentions for Organigram Global. Canopy Growth's average media sentiment score of 1.42 beat Organigram Global's score of 0.91 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Overall Sentiment
Canopy Growth	Positive
Organigram Global	Positive

Summary

Organigram Global beats Canopy Growth on 8 of the 13 factors compared between the two stocks.

How does Canopy Growth compare to SNDL?

SNDL (NASDAQ:SNDL) and Canopy Growth (NASDAQ:CGC) are related small-cap companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

SNDL has a beta of 0.93, suggesting that its stock price is 7% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

SNDL has higher revenue and earnings than Canopy Growth. SNDL is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.49	-$11.29M	-$0.06	N/A
Canopy Growth	$251.01M	1.21	-$190.29M	-$0.45	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, SNDL had 12 more articles in the media than Canopy Growth. MarketBeat recorded 21 mentions for SNDL and 9 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 1.42 beat SNDL's score of 0.44 indicating that Canopy Growth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SNDL	7 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Canopy Growth	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SNDL has a net margin of -6.39% compared to Canopy Growth's net margin of -65.33%. SNDL's return on equity of -1.68% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-6.39%	-1.68%	-1.39%
Canopy Growth	-65.33%	-21.91%	-14.34%

3.3% of Canopy Growth shares are held by institutional investors. 0.4% of Canopy Growth shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

SNDL beats Canopy Growth on 8 of the 15 factors compared between the two stocks.

How does Canopy Growth compare to Tilray Brands?

Canopy Growth (NASDAQ:CGC) and Tilray Brands (NASDAQ:TLRY) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

In the previous week, Tilray Brands had 4 more articles in the media than Canopy Growth. MarketBeat recorded 13 mentions for Tilray Brands and 9 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 1.42 beat Tilray Brands' score of 0.87 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tilray Brands	5 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tilray Brands has a consensus target price of $5.90, indicating a potential upside of 123.48%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Tilray Brands	2 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.38

Tilray Brands has a net margin of -16.91% compared to Canopy Growth's net margin of -65.33%. Tilray Brands' return on equity of -10.39% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-65.33%	-21.91%	-14.34%
Tilray Brands	-16.91%	-10.39%	-7.38%

3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 9.4% of Tilray Brands shares are owned by institutional investors. 0.4% of Canopy Growth shares are owned by company insiders. Comparatively, 1.6% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Tilray Brands has lower revenue, but higher earnings than Canopy Growth. Tilray Brands is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.21	-$190.29M	-$0.45	N/A
Tilray Brands	$210.48M	1.85	-$121.40M	-$1.40	N/A

Canopy Growth has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.91, indicating that its share price is 91% more volatile than the broader market.

Summary

Tilray Brands beats Canopy Growth on 13 of the 17 factors compared between the two stocks.

Get Canopy Growth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CGC vs. The Competition

Export

Metric	Canopy Growth	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$295.64M	$13.66B	$7.87B	$12.26B
Dividend Yield	N/A	2.57%	2.48%	4.43%
P/E Ratio	-1.46	31.43	35.91	32.13
Price / Sales	1.18	6.65	8.27	5.86
Price / Cash	N/A	15.20	21.04	23.34
Price / Book	0.58	5.69	4.99	4.12
Net Income	-$190.29M	$2.83B	$3.50B	$381.38M
7 Day Performance	-2.63%	0.71%	1.15%	0.43%
1 Month Performance	-26.58%	-5.87%	-5.22%	-5.93%
1 Year Performance	-46.07%	-6.85%	0.88%	-5.89%

Canopy Growth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CGC Canopy Growth	1.0849 of 5 stars	$0.66 -2.5%	N/A	-46.0%	$295.64M	$251.01M	N/A	1,128	Positive News Upcoming Earnings
ACB Aurora Cannabis	1.0227 of 5 stars	$3.90 +0.5%	N/A	-17.6%	$255.01M	$247.82M	N/A	1,028
CRON Cronos Group	2.9857 of 5 stars	$3.31 -1.2%	$2.30 -30.5%	+36.6%	$1.23B	$146.59M	30.45	610	Upcoming Earnings
OGI Organigram Global	1.1646 of 5 stars	$0.94 +1.4%	N/A	-40.0%	$130.63M	$185.07M	N/A	1,139	Analyst Upgrade
SNDL SNDL	1.0538 of 5 stars	$1.27 -1.6%	N/A	-39.8%	$332.04M	$677.32M	N/A	2,751	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CGC) was last updated on 10/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canopy Growth (CGC) Competitors

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

How does Canopy Growth compare to Aurora Cannabis?

Summary

How does Canopy Growth compare to Cronos Group?

Summary

How does Canopy Growth compare to Organigram Global?

Summary

How does Canopy Growth compare to SNDL?

Summary

How does Canopy Growth compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CGC vs. The Competition

Canopy Growth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Canopy Growth (CGC) Competitors

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

How does Canopy Growth compare to Aurora Cannabis?

Do insiders and institutionals believe in ACB or CGC?

Which has more volatility and risk, ACB or CGC?

Is ACB or CGC more profitable?

Which has better earnings & valuation, ACB or CGC?

Does the media refer more to ACB or CGC?

Do analysts prefer ACB or CGC?

Summary

How does Canopy Growth compare to Cronos Group?

Which has higher valuation and earnings, CRON or CGC?

Is CRON or CGC more profitable?

Does the media prefer CRON or CGC?

Do analysts prefer CRON or CGC?

Do institutionals & insiders have more ownership in CRON or CGC?

Which has more risk & volatility, CRON or CGC?

Summary

How does Canopy Growth compare to Organigram Global?

Is CGC or OGI more profitable?

Do insiders and institutionals hold more shares of CGC or OGI?

Which has more volatility & risk, CGC or OGI?

Which has better valuation and earnings, CGC or OGI?

Do analysts recommend CGC or OGI?

Does the media favor CGC or OGI?

Summary

How does Canopy Growth compare to SNDL?

Which has more volatility & risk, SNDL or CGC?

Which has stronger valuation and earnings, SNDL or CGC?

Do analysts rate SNDL or CGC?

Does the media prefer SNDL or CGC?

Is SNDL or CGC more profitable?

Do institutionals and insiders hold more shares of SNDL or CGC?

Summary

How does Canopy Growth compare to Tilray Brands?

Does the media favor CGC or TLRY?

Do analysts prefer CGC or TLRY?

Is CGC or TLRY more profitable?

Do insiders & institutionals believe in CGC or TLRY?

Which has preferable earnings & valuation, CGC or TLRY?

Which has more risk and volatility, CGC or TLRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CGC vs. The Competition

Canopy Growth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools